According to the CDC, around 5,000 people in the U.S. are diagnosed with ALS every year. There is no cure for this neurological illness. Although anglers across the Northland were taking advantage of ...

Dr. Jinsy Andrews, director of NYU Langone’s ALS Center, stopped by NY1 on Wednesday and got straight into how treatment for ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder of unknown cause, in which motor nerve cells of the brain and spinal cord that transmit signals to muscles progressively ...

The search for an ALS cure, which has remained a mystery to the health care community, is now being sought out with the help of artificial intelligence. AI is being used to better coordinate all the ...

COYA 302, an injection therapy in development for the treatment of ALS, has been awarded fast track status by the U.S. Food and Drug Administration. The therapy aims to slow ALS progression by ...

The FDA has granted Coya 302 a fast-track designation for ALS, according to a press release from Coya Therapeutics. “ALS is a ...

Add Yahoo as a preferred source to see more of our stories on Google. According to the ALS Association, most patients of the disease die within five years of diagnosis. Reporting for TODAY, NBC’s Anne ...

The ALS Network’s 23rd annual Inland Empire Walk and Roll to Cure ALS, formerly the Walk to Defeat ALS, will be held Oct. 19 at Miller Park Amphitheater, 17002 Arrow Blvd., Fontana. The Walk and Roll ...

Dr. Rakesh Parekh was in his mid-40s when he first noticed something was wrong: During his workouts, his left arm was weaker and struggled to keep up. Initially, Parekh, an emergency medicine doctor ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved RELYVRIO™ ...

I was there, as I have been the past several years, to support my father-in-law, John Solomonson. He's the reason I moved to Oregon. It was about six years ago and John was visiting us in New York. We ...